» Articles » PMID: 33575035

Association Between Optical Coherence Tomography Measurements and Clinical Parameters in Idiopathic Intracranial Hypertension

Abstract

Purpose: To correlate optical coherence tomography (OCT) measurements with clinical parameters in idiopathic intracranial hypertension (IIH).

Methods: A cross-sectional study was conducted with 22 patients with IIH and 11 controls. All participants underwent comprehensive ophthalmological examination followed by spectral-domain OCT (SD-OCT) and standard automated perimetry using the 30-2 program of the Humphrey visual field analyzer. Correlations between ganglion cell complex (GCC) thickness and retinal nerve fiber layer (RNFL) thickness, as measured by SD-OCT, and clinical parameters were assessed using generalized estimating equations.

Result: The mean age of the participants was 35.0 ± 10.83 years. The groups were similar regarding age, but were significantly different regarding sex and visual acuity (=0.001 and =0.038, respectively). The GCC was significantly thinner in the IIH group, with a mean of 90.535 ± 9.766 m compared to 98.119 ± 6.988 m for the controls (=0.023). There was a significant association between GCC thickness and optic disc pallor (=0.016) and between edema and visual acuity (=0.037). No significant difference was found in RNFL thickness between patients and controls.

Conclusion: The GCC was thinner in the patients with IIH compared to the controls, and there was an association between GCC and optic disc pallor. This might suggest a role for OCT parameters when the structural changes that occur in IIH are investigated, possibly guiding clinical decision making.

Citing Articles

Macular exudate in idiopathic intracranial hypertension affects outer retina and visual acuity.

Cao L, Wang H, Kwapong W, Wan J, Yan Y, Liu G BMJ Open Ophthalmol. 2024; 9(1).

PMID: 39317461 PMC: 11423724. DOI: 10.1136/bmjophth-2024-001810.


Exploring the utility of retinal optical coherence tomography as a biomarker for idiopathic intracranial hypertension: a systematic review.

Senthil M, Anand S, Chakraborty R, Bordon J, Constable P, Brown S J Neurol. 2024; 271(8):4769-4793.

PMID: 38856724 PMC: 11319609. DOI: 10.1007/s00415-024-12481-3.


Optic Nerve Head Changes Measured by Swept Source Optical Coherence Tomography and Angiography in Patients with Intracranial Hypertension.

Wang H, Cao L, Kwapong W, Liu G, Wang R, Liu J Ophthalmol Ther. 2023; 12(6):3295-3305.

PMID: 37792243 PMC: 10640446. DOI: 10.1007/s40123-023-00822-w.

References
1.
Huang-Link Y, Al-Hawasi A, Oberwahrenbrock T, Jin Y . OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2015; 130:122-7. DOI: 10.1016/j.clineuro.2014.12.021. View

2.
Sinclair A, Burdon M, Nightingale P, Matthews T, Jacks A, Lawden M . Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension. J Neurol. 2012; 259(7):1406-12. DOI: 10.1007/s00415-011-6365-6. View

3.
Kaufhold F, Kadas E, Schmidt C, Kunte H, Hoffmann J, Zimmermann H . Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT. PLoS One. 2012; 7(5):e36965. PMC: 3352870. DOI: 10.1371/journal.pone.0036965. View

4.
Chen J, Thurtell M, Longmuir R, Garvin M, Wang J, Wall M . Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension. Invest Ophthalmol Vis Sci. 2015; 56(6):3850-9. PMC: 4697859. DOI: 10.1167/iovs.15-16450. View

5.
Ball A, Clarke C . Idiopathic intracranial hypertension. Lancet Neurol. 2006; 5(5):433-42. DOI: 10.1016/S1474-4422(06)70442-2. View